AJP - Endo AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 285: E708-E717, 2003. First published June 3, 2003; doi:10.1152/ajpendo.00572.2002
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/4/E708    most recent
00572.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGinn, S.
Right arrow Articles by Pollock, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGinn, S.
Right arrow Articles by Pollock, C. A.

High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase

S. McGinn,1 S. Saad,1 P. Poronnik,1,2 and C. A. Pollock1

1Renal Research Group, Kolling Institute, Royal North Shore Hospital, University of Sydney, New South Wales 2065; and 2School of BioMedical Sciences, University of Queensland, Queensland 4072, Australia

Submitted 22 December 2002 ; accepted in final form 11 May 2003

The mitogen-activated protein (MAP) kinases contribute to altered cell growth and function in a variety of disease states. However, their role in the endothelial complications of diabetes mellitus remains unclear. Human endothelial cells were exposed for 72 h to 5 mM (control) or 25 mM (high) glucose or 5 mM glucose plus 20 mM mannitol (osmotic control). The roles of p38 and p42/44 MAP kinases in the high glucose-induced growth effects were determined by assessment of phosphorylated MAP kinases and their downstream activators by Western blot and by pharmacological inhibition of these MAP kinases. Results were expressed as a percentage (means ± SE) of control. High glucose increased the activity of total and phosphorylated p38 MAP kinase (P < 0.001) and p42/44 MAP kinase (P < 0.001). Coexposure of p38 MAP kinase blocker with high glucose reversed the antiproliferative but not the hypertrophic effects associated with high-glucose conditions. Transforming growth factor (TGF)-{beta}1 increased the levels of phosphorylated p38 MAP kinase, and p38 MAP kinase blockade reversed the antiproliferative effects of this cytokine. The high glucose-induced increase in phosphorylated p38 MAP kinase was reversed in the presence of TGF-{beta}1 neutralizing antibody. Although hyperosmolarity also induced antiproliferation (P < 0.0001) and cell hypertrophy (P < 0.05), there was no change in p38 activity, and therefore inhibition of p38 MAP kinase had no influence on these growth responses. Blockade of p42/44 MAP kinase had no effect on the changes in endothelial cell growth induced by either high glucose or hyperosmolarity. High glucose increased p42/44 and p38 MAP kinase activity in human endothelial cells, but only p38 MAP kinase mediated the antiproliferative growth response through the effects of autocrine TGF-{beta}1. High glucose-induced endothelial cell hypertrophy was independent of activation of the MAP kinases studied. In addition, these effects were independent of any increase in osmolarity associated with high-glucose exposure.

high glucose; endothelial cell; growth; p38 mitogen-activated protein kinase; p42/44 mitogen-activated protein kinase; transforming growth factor-{beta}1



Address for reprint requests and other correspondence: C. Pollock, Dept of Medicine, Level 3, Wallace Freeborn Royal North Shore Hospital, St Leonards 2065, Australia (E-mail: carpol{at}med.usyd.edu.au).




This article has been cited by other articles:


Home page
J. Dent. Res.Home page
H.-J. Chae, M.-S. Ha, D.-H. Yun, H.-O. Pae, H.-T. Chung, S.-W. Chae, Y.-K. Jung, and H.-R. Kim
Mechanism of Cyclosporine-induced Overgrowth in Gingiva.
J. Dent. Res., June 1, 2006; 85(6): 515 - 519.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Varma, B. K. Lal, R. Zheng, J. W. Breslin, S. Saito, P. J. Pappas, R. W. Hobson II, and W. N. Duran
Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1744 - H1751.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Campbell, W. E. Allen, C. Sawyer, B. Vanhaesebroeck, and E. R. Trimble
Glucose-Potentiated Chemotaxis in Human Vascular Smooth Muscle Is Dependent on Cross-Talk Between the PI3K and MAPK Signaling Pathways
Circ. Res., August 20, 2004; 95(4): 380 - 388.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.